Improvement of neutralizing activity of human scFv antibodies against hepatitis B virus binding using CDR3 VH mutant library

Viral Immunology

Volumn 19, Issue 1, 2006, Pages 115-123

  Park, Sae Gwang ^a,c,d   Jung, Young Joo ^a   Lee, Young Yi ^a,b   Yang, Cheul Min ^a   Kim, Ik Jung ^b   Chung, Jun Ho ^c   Kim, Ik Sang ^c   Lee, Youn Jae ^a   Park, Sung Jae ^a   Lee, Jeong Nyeo ^a   Seo, Su Kil ^a   Park, Yong Hong ^a   Choi, In Hak ^a,d  

^a Inje University   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; NEUTRALIZING ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DNA SEQUENCE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PASSIVE IMMUNIZATION; POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE; VIRION;

AMINO ACID SEQUENCE; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; MUTATION; NEUTRALIZATION TESTS; PEPTIDE LIBRARY; PROTEIN BINDING;

HEPATITIS B VIRUS;

EID: 33645470795     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.115     Document Type: Article

References (40)

1. Al-Lazikani, B., A.M. Lesk, and C. Chothia. 1997. Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273:927-948.
2. rd. 1994. The pharmacology of monoclonal antibodies. Springer-Verlag, Berlin.
3. Barbas, C. F., 3rd, D.R. Burton, J.K. Scott, and GJ. Silverman. 2001. Phage Display; A Laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
4. Bergelson, J.M., J.A. Cunningham, G. Droguett, E.A. Kurt-Jones, A. Krithivas, J.S. Hong, M.S. Horwitz, R.L. Crowell, and R.W. Finberg. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
5. Brekke, O.K., and G.A. Loset. 2003. New technologies in therapeutic antibody development. Curr. Opin. Pharmacol. 3:544-550.
6. Budkowska, A., P. Bedossa, F. Groh, A. Louise, and J. Pillot. 1995. Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain. J. Virol. 69:840-848.
7. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
8. Choi, I.H., S.G. Park, J.H. Chung, I.J. Kim, and H.J. Hong. 1998. Generation of human Fab monoclonal antibodies against pre-S1 of hepatitis B virus using repertoire cloning. Hybridoma 17: 535-540.
9. Clackson, T., H.R. Hoogenboom, A.D. Griffiths, and G. Winter. 1991. Making antibody fragments using phage display libraries. Nature 352:624-628.
10. Daugherty, P.S., G. Chen, B.L. Iverson, and G. Georgiou. 2000. Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proc. Natl. Acad. Sci. U.S.A. 97:2029-2034.
11. De Falco, S., M.G. Ruvoletto, A. Verdoliva, M. Ruvo, A. Raucci, M. Marino, S. Senatore, G. Cassani, A. Alberti, P. Pontisso, and G. Fassina. 2001. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J. Biol. Chem. 276: 36613-36623.
12. Faelber, K., D. Kirchhofer, L. Presta, R.F. Kelley, and Y.A. Muller. 2001. The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites. J. Mol. Biol. 313:83-97.
13. Hawkins, R.E., S.J. Russell, and G. Winter. 1992. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J. Mol. Biol. 226:889-896.
14. Hong, H.J., C.J. Ryu, H. Hur, S. Kim, H.K. Oh, M.S. Oh, and S.Y. Park. 2004. In vivo neutralization of hepatitis B virus infection by an anti-pre-S1 humanized antibody in chimpanzees. Virology 318:134-141.
15. Kuroki, K., M. Floreani, L.T. Mimms, and D. Ganem. 1990. Epitope mapping of the Pre-S1 domain of the hepatitis B virus large surface protein. Virology 176:620-624.
16. Kuttner, G., A. Kramer, G. Schmidtke, E. Giessmann, L. Dong, D. Roggenbuck, C. Scholz, M. Seifert, R.D. Stigler, J. Schneider-Mergener, T. Porstmann, and W. Hohne. 1999. Characterization of neutralizing anti-pre-S1 and anti-pre-S2 (HBV) monoclonal antibodies and their fragments. Mol. Immunol. 36:669-683.
17. Le Seyec, J., P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon, 1999, Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J. Virol. 73:2052-2057.
18. Maeng, C.Y., C.J. Ryu, P. Gripon, C. Guguen-Guillouzo, and H.J. Hong. 2000. Fine mapping of virus-neutralizing epitopes on hepatitis B virus Pre-S1. Virology 270:9-16.
19. Malmborg, A.C., M. Duenas, M. Ohlin, E. Soderlind, and C.A. Borrebaeck. 1996. Selection of binders from phage displayed antibody libraries using the BIAcore biosensor. J. Immunol. Methods 198:51-57.
20. McCafferty, J., A.D. Griffiths, G. Winter, and D.J. Chiswell. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552-554.
21. Montgomery, R.I., M.S. Warner, B.J. Lum, and P.G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
22. Mutuberria, R., H.R. Hoogenboom, E. van der Linden, A.P. de Bruine, and R.C. Roovers. 1999. Model systems to study the parameters determining the success of phage antibody selections on complex antigens. J. Immunol. Methods 231:65-81.
23. Neurath, A.R., S.B. Kent, N. Strick, and K. Parker. 1986. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429-436.
24. Neurath, A.R., S.B. Kent, N. Strick, P. Taylor and C.E. Stevens. 1985. Hepatitis B virus contains pre-S gene-encoded domains. Nature 315:154-156.
25. Park, S.G., Y.J. Jeong, Y.Y. Lee, I.J. Kim, S.K. Seo, E.J. Kim, H.C. Jung, J.G. Pan, S.J. Park, Y.J. Lee, L.S. Kim, and I.H. Choi. 2005. Hepatitis B virus-neutralizing antipre-S1 human antibody fragments from large naive antibody phage library. Antiviral Res. 68:109-115.
26. Park, S.G., J.S. Lee, E.Y. Je, I.J. Kim, J.H. Chung, and I.H. Choi. 2000. Affinity maturation of natural antibody using a chain shuffling technique and the expression of recombinant antibodies in Escherichia coli. Biochem. Biophys. Res. Commun. 275:553-557.
27. Petit, M.A., S. Dubanchet, and F. Capel. 1989. A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus. Mol. Immunol. 26:531-537.
28. Petit, M.A., S. Dubanchet, F. Capel, P. Voet, C. Dauguet, and P. Hauser. 1991. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-pre-S1(21-47). Virology 180:483-491.
29. Pontisso, P., M.A. Petit, M.J. Bankowski, and M.E. Peeples. 1989. Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J. Virol. 63:1981-1988.
30. Pontisso, P., M.G. Ruvoletto, W.H. Gerlich, K.H. Heermann, R. Bardini, and A. Alberti. 1989. Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology 173:522-530.
31. Ryu, C.J., Y.K. Kim, H. Hur, H.S. Kim, J.M. Oh, Y.J. Kang, and H.J. Hong. 2000. Mouse monoclonal antibodies to hepatitis B virus pre-S1 produced after immunization with recombinant pre-S1 peptide. Hybridoma 19:185-189.
32. Schaaper, R.M. 1988. Mechanisms of mutagenesis in the Escherichia coli mutator mutD5: role of DNA mismatch repair. Proc. Natl. Acad. Sci. U.S.A. 85:8126-8130.
33. Sells, M.A., M.L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A. 84:1005-1009.
34. Shawler, D.L., R.M. Bartholomew, L.M. Smith, and R.O. Dillman. 1985. Human immune response to multiple injections of murine monoclonal IgG. J. Immunol. 135: 1530-1535.
35. Sidhu, S.S., B. Li, Y. Chen, F.A. Fellouse, C. Eigenbrot, and G. Fuh. 2004. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. J. Mol. Biol. 338:299-310.
36. Smith, G.P. 1985. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315-1317.
37. Vajdos, F.F., C.W. Adams, T.N. Breece, L.G. Presta, A.M. de Vos, and S.S. Sidhu. 2002. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. J. Mol. Biol. 320:415-428.
38. Valjakka, J., A. Hemminki, S. Niemi, H. Soderlund, K. Takkinen, and J. Rouvinen. 2002. Crystal structure of an in vitro affinity- and specificity-matured anti-testosterone Fab in complex with testosterone. Improved affinity results from small structural changes within the variable domains. J. Biol. Chem. 277:44021-4407.
39. Xu, J.L., and M.M. Davis. 2000. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13:37-45.
40. rd. 1995. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J. Mol. Biol. 254:392-403.